Emily DiMango, MD

Pulmonology
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Overview

Dr. DiMango is Director of the Columbia University Gunnar Esiason Adult Cystic Fibrosis (CF) Program and the Asthma Research Program. The adult CF program cares for nearly 300 people with CF, with support from a dedicated multi-disciplinary team. She is co-Director of the Cystic Fibrosis Foundation Therapeutics Development Network at Columbia. She currently serves as Principal Investigator for numerous research projects in the areas of cystic fibrosis and asthma. Dr. DiMango currently serves as the national Chair of the Cystic Fibrosis Foundation (CFF) Therapeutics Development Network Program Protocol Review Committee.

Areas of Expertise / Conditions Treated

  • Allergy and Asthma Management
  • Asthma
  • Bronchiectasis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • General Pulmonology
  • Pulmonary Disease
  • Pulmonary Medicine

Academic Appointments

  • Professor of Medicine at CUMC

Administrative Titles

  • Director, Gunnar Esiason Adult Cystic Fibrosis Center
  • Assistant Dean, Columbia University Vagelos College of Physicians and Surgeons

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

622 West 168th Street
Room PH 859
New York, NY 10032
Primary
Phone:

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • NY Signature
  • Student Health

Affinity Health Plan

  • Medicaid Managed Care

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicare Managed Care
  • New Jersey Services (Medicaid Managed Care)
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicare Managed Care

Local 1199

  • Local 1199
  • NYP Employee Plan

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management

RiverSpring

  • Special Needs

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicare Managed Care
  • New Jersey Services (Medicaid Managed Care)

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, New York University School of Medicine
  • Internship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Pulmonary Disease Medicine
  • Internal Medicine

Honors & Awards

  • Ewig Clinical Scholar
  • Tau Award for Humanism in Medicine
  • Castle Connolly Top Doctors
America's Top Doctor
NY Top Doctor

Research

Research Interests

  • Adult CF
  • Asthma
  • Bronchiectasis
  • Cystic Fibrosis Clinical Research

Selected Publications

  • Boushey, H, Sorkness, C, King, DiMango, E, et al. Regular vs. intermittent controller therapy for mild persistent asthma. New England Journal of Medicine. 2005.
  • Deykin, A, Lazarus, S…. DiMango, E. Sputum Eosinophils Predict Asthma Control Following Discontinuation of Inhaled Corticosteroids. Journal of Asthma and Clinical Immunology 2005; 115(4): 720-727.
  • Wechsler ME, Lehman E, Lazarus, DiMango, E….. Beta adrenergic receptor polymorphisms and response to salmeterol. Beta-adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med. 2006; 173(5):519-26.
  • Deykin A, Wechsler ME, Boushey HA,… DiMango, E…. Combination therapy with a long acting b-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med 2007 Feb 1;175 (3):228-34.
  • Martin, RJ, Szefler, SJ, King T….DiMango, E… The Predicting Response to Inhaled Corticosteroid Efficacy. Journal of Asthma and Clinical Immunology 2007 Jan; 119(1):73-80
  • Lazarus, SC, Chinchilli VM, Rollings NJ…DiMango E, … Smoking Affects Response to Inhaled corticosteroids or leukotriene receptor antagonists in Asthma. Am J Respir Crit Care Med. 2007
  • American Lung Association Asthma Clinical Research Centers; Mastronarde, JG, Wise RA, Shade DM, Olopade, CO, Scharf, SM. Sleep quality in asthma: results of a larage prospective clinical trial. J Asthma. 2008 Apr, 45 (3): 183-9.
  • American Lung Association Asthma Clinical Research Centers; Mastronarde, JG, Anthonisen, NR, Castro M, Holbrook, JT, Leone FT. Efficacy of esomeprazole for treatment of poorly controlled asthma. NEJM. 2009 Apr 9; 360 (15): 1487-99.
  • **DiMango, E, Holbrook, J, Simpson, Reibman, J, Richter, J, Mastronarde, J, Wise, R for the American Lung Association Asthma Clinical Research Centers. Effects of Asymptomatic Proximal and Distal Gastroesophageal Reflux on asthma severity, AJRCCM 2009, epub
  • **Keating, C, Liu, X, DiMango, E. Clinical and demographic characteristics of patients diagnosed with cystic fibrosis after the age of 18, under review.